Fractures after long-term alendronate therapy [1]

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 4, 2001, Pages 1835-

  Ott, S M ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID;

BONE STRENGTH; DRUG EFFECT; FRACTURE; HUMAN; LETTER; LONG TERM CARE; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 17744369253     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.4.7436-1     Document Type: Letter

References (4)

1. Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women
2. Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis
3. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
4. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures